23101093|t|Cholinesterase inhibitors in Alzheimer s disease: Executive summary of final report A05-19A, Version 1.0
23101093|a|The aims of this evaluation were: the evaluation of long-term treatment with a ChEI in Alzheimer s disease compared with placebo; the evaluation of long-term treatment with a ChEI in Alzheimer s disease compared with treatment with a different drug or non-drug intervention. The focus of this evaluation was on patient-relevant therapy goals.
23101093	29	48	Alzheimerâs disease	Disease	MESH:D000544
23101093	184	188	ChEI	Chemical	-
23101093	192	211	Alzheimerâs disease	Disease	MESH:D000544
23101093	280	284	ChEI	Chemical	-
23101093	288	307	Alzheimerâs disease	Disease	MESH:D000544
23101093	416	423	patient	Species	9606

